Understanding these mechanisms helps explain why treatments that improve metabolic and cardiovascular health may influence dementia risk
Underscoring the potential health consequences from dosing errors and exposure to the wrong ingredients, in September 2025, the FDA reported receiving 1,150 reports of adverse events associated with compounded GLP-1 drugs, including hospitalizations and some deaths
Dental pulp stem cells overexpressing hepatocyte growth factor facilitate the repair of DSS-induced ulcerative colitis
Cell 169 , 1276-1290 e1217
How Biomarkers and Genetic Predisposition Affect Your Cost-Benefit Analysis Individual metabolic markersincluding insulin sensitivity, baseline HbA1c, BMI trajectory, and inflammatory statuscan inform whether you benefit from tirzepatide initiation at lower doses ($289/month range) or higher concentrations requiring premium pricing